tiprankstipranks
Atossa Therapeutics (ATOS)
NASDAQ:ATOS
US Market
ATOS
Atossa Therapeutics
RESEARCH TOOLSreports
Want to see ATOS full AI Analyst Report?

Atossa Therapeutics (ATOS) Stock News & Sentiment

2,566 Followers
Atossa: Patent De‑Risking and Endoxifen Franchise Optionality Support Buy Rating and Upside to Target Price
Premium
Ratings
Atossa: Patent De‑Risking and Endoxifen Franchise Optionality Support Buy Rating and Upside to Target Price
19d ago
ATOS
Atossa Therapeutics Resolves Endoxifen Patent Disputes, Clarifies Rights
Premium
Company Announcements
Atossa Therapeutics Resolves Endoxifen Patent Disputes, Clarifies Rights
20d ago
8K
ATOS
VTI ETF Inflows Hold Steady Despite AI Sell-Off – 2/24/26
Premium
Market News
VTI ETF Inflows Hold Steady Despite AI Sell-Off – 2/24/26
2M ago
L
CLB
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/23/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/23/26
2M ago
CLB
IMA
Atossa Therapeutics Launches New $50 Million ATM Program
Premium
Company Announcements
Atossa Therapeutics Launches New $50 Million ATM Program
2M ago
8K
ATOS
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/20/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/20/26
3M ago
L
CLB
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/19/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/19/26
3M ago
L
CLB
More ATOS News >

ATOS News on the Web

Atossa: Patent De‑Risking and Endoxifen Franchise Optionality Support Buy Rating and Upside to Target Price
TipRanks News
Neutral
Atossa Therapeutics Resolves Endoxifen Patent Disputes, Clarifies Rights
TipRanks News
Neutral
Atossa Therapeutics target adjusted to $25 from $7 at H.C. Wainwright
TipRanks News
Bullish
Atossa Therapeutics (ATOS) Reports Wider-Than-Expected Loss
GuruFocus News
Bearish
Atossa Therapeutics reports 2025 EPS ($4.04), consensus ($3.91)
TipRanks News
Bullish
Atossa Therapeutics announces addition of two biopharma executives to team
TipRanks News
Bullish
Maxim Group Sticks to Their Buy Rating for Atossa Therapeutics (ATOS)
TipRanks News
Bullish
VTI ETF Inflows Hold Steady Despite AI Sell-Off – 2/24/26
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
ATOS
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.25 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ATOS’s Media Buzz Sentiment?
2 articles about ATOS were published this week. In an average week, 1.25 articles are published.
    What is ATOS’s weekly average amount of articles?
    In an average week, 1.25 articles about ATOS are published.
      What is ATOS’s News Sentiment?
      50% of articles about ATOS were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week